Cargando…

Genome-wide CRISPR/Cas9 screening in human iPS derived cardiomyocytes uncovers novel mediators of doxorubicin cardiotoxicity

Human induced pluripotent stem (iPS) cell technologies coupled with genetic engineering now facilitate the study of the molecular underpinnings of disease in relevant human cell types. Application of CRISPR/Cas9-based approaches for genome-scale functional screening in iPS-derived cells, however, ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sapp, Valerie, Aguirre, Aitor, Mainkar, Gayatri, Ding, Jeffrey, Adler, Eric, Liao, Ronglih, Sharma, Sonia, Jain, Mohit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260754/ https://www.ncbi.nlm.nih.gov/pubmed/34230586 http://dx.doi.org/10.1038/s41598-021-92988-1

Ejemplares similares

Cardiomyocyte Atrophy, an Underestimated Contributor in Doxorubicin-Induced Cardiotoxicity
por: Chen, De-Shu, et al.
Publicado: (2022)

Myogenic Differentiation from MYOGENIN-Mutated Human iPS Cells by CRISPR/Cas9
por: Higashioka, Koki, et al.
Publicado: (2017)

The Exciting Realities and Possibilities of iPS-Derived Cardiomyocytes
por: Takahashi, Fuga, et al.
Publicado: (2023)

Modeling Doxorubicin-Induced Cardiotoxicity in Human Pluripotent Stem Cell Derived-Cardiomyocytes
por: Maillet, Agnes, et al.
Publicado: (2016)

Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity
por: Guo, Rui, et al.
Publicado: (2018)

Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes
por: Zhao, Liqun, et al.
Publicado: (2017)

Cinnamaldehyde alleviates doxorubicin-induced cardiotoxicity by decreasing oxidative stress and ferroptosis in cardiomyocytes
por: Mao, Meijiao, et al.
Publicado: (2023)

Generation of a homozygous CIITA knockout iPS cell line using the CRISPR-Cas9 system
por: Romano, Elena, et al.
Publicado: (2021)

Rosmarinic acid alleviates cardiomyocyte apoptosis via cardiac fibroblast in doxorubicin-induced cardiotoxicity
por: Zhang, Xin, et al.
Publicado: (2019)

Astragalus polysaccharide restores autophagic flux and improves cardiomyocyte function in doxorubicin-induced cardiotoxicity
por: Cao, Yuan, et al.
Publicado: (2016)

Correction: Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity
por: Guo, Rui, et al.
Publicado: (2019)

Cardiomyocyte Stim1 Deficiency Exacerbates Doxorubicin Cardiotoxicity by Magnification of Endoplasmic Reticulum Stress
por: Zhu, Jiang, et al.
Publicado: (2021)

Peroxiredoxin-1 Overexpression Attenuates Doxorubicin-Induced Cardiotoxicity by Inhibiting Oxidative Stress and Cardiomyocyte Apoptosis
por: Jiang, Lai, et al.
Publicado: (2020)

Doxorubicin-induced cardiotoxicity enhance SARS-CoV-2 infection susceptibility in human cardiomyocytes
por: Lazzarini, Edoardo, et al.
Publicado: (2022)

Electronic cigarette extract induced toxic effect in iPS-derived cardiomyocytes
por: Basma, Hesham, et al.
Publicado: (2020)

INKing the Cardiotoxicity Out of Doxorubicin
por: Guo, Zhen, et al.
Publicado: (2023)

GCN2 deficiency ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and myocardial oxidative stress
por: Wang, Yue, et al.
Publicado: (2018)

Xinfuli improves cardiac function, histopathological changes and attenuate cardiomyocyte apoptosis in rats with doxorubicin-induced cardiotoxicity
por: Lu, Pei-Pei, et al.
Publicado: (2016)

FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT
por: Zhang, Xin, et al.
Publicado: (2019)

Wogonin reduces cardiomyocyte apoptosis from mitochondrial release of cytochrome c to improve doxorubicin-induced cardiotoxicity
por: Wei, Yunjie, et al.
Publicado: (2022)

Roflumilast Attenuates Doxorubicin-Induced Cardiotoxicity by Targeting Inflammation and Cellular Senescence in Cardiomyocytes Mediated by SIRT1
por: Zhang, Sheng, et al.
Publicado: (2021)

M2b macrophages protect against doxorubicin induced cardiotoxicity via alternating autophagy in cardiomyocytes
por: Chen, Sida, et al.
Publicado: (2023)

CRISPR/Cas9-mediated editing of PHYTOENE DESATURASE gene in onion (Allium cepa L.)
por: Mainkar, Pawan, et al.
Publicado: (2023)

Efficient CRISPR/Cas9-mediated editing of trinucleotide repeat expansion in myotonic dystrophy patient-derived iPS and myogenic cells
por: Dastidar, Sumitava, et al.
Publicado: (2018)

Highly efficient biallelic genome editing of human ES/iPS cells using a CRISPR/Cas9 or TALEN system
por: Takayama, Kazuo, et al.
Publicado: (2017)

Revealing potential cardiac manifestation of ADPKD using iPS cell-derived cardiomyocytes
por: Morizane, Ryuji
Publicado: (2019)

Exogenous 8-hydroxydeoxyguanosine attenuates doxorubicin-induced cardiotoxicity by decreasing pyroptosis in H9c2 cardiomyocytes
por: Hwang, Soyoung, et al.
Publicado: (2022)

COX5A Alleviates Doxorubicin-Induced Cardiotoxicity by Suppressing Oxidative Stress, Mitochondrial Dysfunction and Cardiomyocyte Apoptosis
por: Zhang, Peipei, et al.
Publicado: (2023)

Protein-encapsulated doxorubicin reduces cardiotoxicity in hiPSC-cardiomyocytes and cardiac spheroids while maintaining anticancer efficacy
por: Arzt, Madelyn, et al.
Publicado: (2023)

Generation and Characterization of a MYF5 Reporter Human iPS Cell Line Using CRISPR/Cas9 Mediated Homologous Recombination
por: Wu, Jianbo, et al.
Publicado: (2016)

A cytokine screen using CRISPR-Cas9 knock-in reporter pig iPS cells reveals that Activin A regulates NANOG
por: Xu, Junjun, et al.
Publicado: (2020)

Role of acetylation in doxorubicin-induced cardiotoxicity
por: Li, Daisong, et al.
Publicado: (2021)

Dipyridamole ameliorates doxorubicin-induced cardiotoxicity
por: Alyasiry, Esraa, et al.
Publicado: (2022)

Using iPS cell-derived neurons to uncover cellular phenotypes associated with Timothy Syndrome
por: Paşca, Sergiu P., et al.
Publicado: (2011)

Variation in RARG increases susceptibility to doxorubicin-induced cardiotoxicity in patient specific induced pluripotent stem cell-derived cardiomyocytes
por: Christidi, Effimia, et al.
Publicado: (2020)

miR-488-3p Protects Cardiomyocytes against Doxorubicin-Induced Cardiotoxicity by Inhibiting CyclinG1
por: Yan, Mingjing, et al.
Publicado: (2022)

Chromosomal translocation t(11;14) and p53 deletion induced by the CRISPR/Cas9 system in normal B cell-derived iPS cells
por: Azami, Yusuke, et al.
Publicado: (2021)

Beyond iPS!
Publicado: (2012)

Morphine Enhances Doxorubicin-Induced Cardiotoxicity in the Rat
por: Hole, Lisa Drange, et al.
Publicado: (2014)

The true colors of autophagy in doxorubicin-induced cardiotoxicity
por: Xiao, Bin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7n88l3bhjtme8drutf5n8uofn6